Intravenous Immunoglobulin in the Management of Lupus Erythematosus Panniculitis

Lupus erythematosus panniculitis (LEP) is a rare variant of cutaneous lupus erythematosus (CLE). It is characterized by the presence of a chronic inflammatory process involving the deep dermis and subcutaneous tissues. It commonly presents as deep indurated nodules or sharply demarcated plaques. Ant...

Full description

Saved in:
Bibliographic Details
Published in:Curēus (Palo Alto, CA) CA), 2020-01, Vol.12 (1), p.e6790
Main Authors: AlQadri, Nada G, AlNooh, Bayan, AlTewerki, Malak M, Almotairi, Ahmad, Alajlan, Saad
Format: Article
Language:English
Subjects:
Alopecia
Atrophy
Baldness
Blood & organ donations
Case reports
Dermatitis
Dermatology
Drug dosages
Immunoglobulins
Internal Medicine
Lupus
Pain
Rheumatology
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page
container_issue 1
container_start_page e6790
container_title Curēus (Palo Alto, CA)
container_volume 12
creator AlQadri, Nada G
AlNooh, Bayan
AlTewerki, Malak M
Almotairi, Ahmad
Alajlan, Saad
description Lupus erythematosus panniculitis (LEP) is a rare variant of cutaneous lupus erythematosus (CLE). It is characterized by the presence of a chronic inflammatory process involving the deep dermis and subcutaneous tissues. It commonly presents as deep indurated nodules or sharply demarcated plaques. Antimalarial medications are considered first-line therapy for most cases of LEP while systemic corticosteroids are saved for more resistant lesions. Intravenous immunoglobulin (IVIG) is made up of concentrated polyclonal immunoglobulin G (IgG) fractionated from the blood of healthy blood donors. Nowadays, it is used for the treatment of numerous autoimmune and systemic inflammatory diseases. In this case, we report the case of a female with multiple LEP and discoid lupus erythematosus (DLE) lesions refractory to multiple standard therapy modalities that responded dramatically to IVIG.
doi_str_mv 10.7759/cureus.6790
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6988482</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2368381422</sourcerecordid><originalsourceid>FETCH-LOGICAL-c264t-a6b6db5b8fa90f56240f3a26d5fe255f435027ecf1151a8b40f48cc6fd6f812d3</originalsourceid><addsrcrecordid>eNpVkcFLwzAUxoMobsydvEvBo3QmaZJmF0Fk6mDiDnoOaZtsHW0yk2aw_96UzTEh8BK-X768lw-AWwQneU6nj2VwKvgJy6fwAgwxYjzliJPLs_0AjL3fQAgRzDHM4TUYZBhiSkg-BMu56ZzcKWODT-ZtG4xdNbYITW2SuLq1Sj6kkSvVKtMlVieLsI3kzO2j1MrO-nhaSmPqMt7pan8DrrRsvBof6wh8v86-Xt7Txefb_OV5kZaYkS6VrGBVQQuu5RRqyjCBOpOYVVQrTKkmGYU4V6VGiCLJiygTXpZMV0xzhKtsBJ4OvttQtKoqVT9HI7aubqXbCytr8V8x9Vqs7E6wKeeE42hwfzRw9ico34mNDc7EngXOGM84IrinHg5U6az3TunTCwiKPgFxSED0CUT67rypE_v339kv23KFFg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2368381422</pqid></control><display><type>article</type><title>Intravenous Immunoglobulin in the Management of Lupus Erythematosus Panniculitis</title><source>Open Access: PubMed Central</source><source>Publicly Available Content Database</source><creator>AlQadri, Nada G ; AlNooh, Bayan ; AlTewerki, Malak M ; Almotairi, Ahmad ; Alajlan, Saad</creator><creatorcontrib>AlQadri, Nada G ; AlNooh, Bayan ; AlTewerki, Malak M ; Almotairi, Ahmad ; Alajlan, Saad</creatorcontrib><description>Lupus erythematosus panniculitis (LEP) is a rare variant of cutaneous lupus erythematosus (CLE). It is characterized by the presence of a chronic inflammatory process involving the deep dermis and subcutaneous tissues. It commonly presents as deep indurated nodules or sharply demarcated plaques. Antimalarial medications are considered first-line therapy for most cases of LEP while systemic corticosteroids are saved for more resistant lesions. Intravenous immunoglobulin (IVIG) is made up of concentrated polyclonal immunoglobulin G (IgG) fractionated from the blood of healthy blood donors. Nowadays, it is used for the treatment of numerous autoimmune and systemic inflammatory diseases. In this case, we report the case of a female with multiple LEP and discoid lupus erythematosus (DLE) lesions refractory to multiple standard therapy modalities that responded dramatically to IVIG.</description><identifier>ISSN: 2168-8184</identifier><identifier>EISSN: 2168-8184</identifier><identifier>DOI: 10.7759/cureus.6790</identifier><identifier>PMID: 32025447</identifier><language>eng</language><publisher>United States: Cureus Inc</publisher><subject>Alopecia ; Atrophy ; Baldness ; Blood &amp; organ donations ; Case reports ; Dermatitis ; Dermatology ; Drug dosages ; Immunoglobulins ; Internal Medicine ; Lupus ; Pain ; Rheumatology</subject><ispartof>Curēus (Palo Alto, CA), 2020-01, Vol.12 (1), p.e6790</ispartof><rights>Copyright © 2020, AlQadri et al.</rights><rights>Copyright © 2020, AlQadri et al. This work is published under http://creativecommons.org/licenses/by/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>Copyright © 2020, AlQadri et al. 2020 AlQadri et al.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2368381422/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2368381422?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,25753,27924,27925,37012,44590,53791,53793,75126</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32025447$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>AlQadri, Nada G</creatorcontrib><creatorcontrib>AlNooh, Bayan</creatorcontrib><creatorcontrib>AlTewerki, Malak M</creatorcontrib><creatorcontrib>Almotairi, Ahmad</creatorcontrib><creatorcontrib>Alajlan, Saad</creatorcontrib><title>Intravenous Immunoglobulin in the Management of Lupus Erythematosus Panniculitis</title><title>Curēus (Palo Alto, CA)</title><addtitle>Cureus</addtitle><description>Lupus erythematosus panniculitis (LEP) is a rare variant of cutaneous lupus erythematosus (CLE). It is characterized by the presence of a chronic inflammatory process involving the deep dermis and subcutaneous tissues. It commonly presents as deep indurated nodules or sharply demarcated plaques. Antimalarial medications are considered first-line therapy for most cases of LEP while systemic corticosteroids are saved for more resistant lesions. Intravenous immunoglobulin (IVIG) is made up of concentrated polyclonal immunoglobulin G (IgG) fractionated from the blood of healthy blood donors. Nowadays, it is used for the treatment of numerous autoimmune and systemic inflammatory diseases. In this case, we report the case of a female with multiple LEP and discoid lupus erythematosus (DLE) lesions refractory to multiple standard therapy modalities that responded dramatically to IVIG.</description><subject>Alopecia</subject><subject>Atrophy</subject><subject>Baldness</subject><subject>Blood &amp; organ donations</subject><subject>Case reports</subject><subject>Dermatitis</subject><subject>Dermatology</subject><subject>Drug dosages</subject><subject>Immunoglobulins</subject><subject>Internal Medicine</subject><subject>Lupus</subject><subject>Pain</subject><subject>Rheumatology</subject><issn>2168-8184</issn><issn>2168-8184</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><recordid>eNpVkcFLwzAUxoMobsydvEvBo3QmaZJmF0Fk6mDiDnoOaZtsHW0yk2aw_96UzTEh8BK-X768lw-AWwQneU6nj2VwKvgJy6fwAgwxYjzliJPLs_0AjL3fQAgRzDHM4TUYZBhiSkg-BMu56ZzcKWODT-ZtG4xdNbYITW2SuLq1Sj6kkSvVKtMlVieLsI3kzO2j1MrO-nhaSmPqMt7pan8DrrRsvBof6wh8v86-Xt7Txefb_OV5kZaYkS6VrGBVQQuu5RRqyjCBOpOYVVQrTKkmGYU4V6VGiCLJiygTXpZMV0xzhKtsBJ4OvttQtKoqVT9HI7aubqXbCytr8V8x9Vqs7E6wKeeE42hwfzRw9ico34mNDc7EngXOGM84IrinHg5U6az3TunTCwiKPgFxSED0CUT67rypE_v339kv23KFFg</recordid><startdate>20200127</startdate><enddate>20200127</enddate><creator>AlQadri, Nada G</creator><creator>AlNooh, Bayan</creator><creator>AlTewerki, Malak M</creator><creator>Almotairi, Ahmad</creator><creator>Alajlan, Saad</creator><general>Cureus Inc</general><general>Cureus</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>5PM</scope></search><sort><creationdate>20200127</creationdate><title>Intravenous Immunoglobulin in the Management of Lupus Erythematosus Panniculitis</title><author>AlQadri, Nada G ; AlNooh, Bayan ; AlTewerki, Malak M ; Almotairi, Ahmad ; Alajlan, Saad</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c264t-a6b6db5b8fa90f56240f3a26d5fe255f435027ecf1151a8b40f48cc6fd6f812d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Alopecia</topic><topic>Atrophy</topic><topic>Baldness</topic><topic>Blood &amp; organ donations</topic><topic>Case reports</topic><topic>Dermatitis</topic><topic>Dermatology</topic><topic>Drug dosages</topic><topic>Immunoglobulins</topic><topic>Internal Medicine</topic><topic>Lupus</topic><topic>Pain</topic><topic>Rheumatology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>AlQadri, Nada G</creatorcontrib><creatorcontrib>AlNooh, Bayan</creatorcontrib><creatorcontrib>AlTewerki, Malak M</creatorcontrib><creatorcontrib>Almotairi, Ahmad</creatorcontrib><creatorcontrib>Alajlan, Saad</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Curēus (Palo Alto, CA)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>AlQadri, Nada G</au><au>AlNooh, Bayan</au><au>AlTewerki, Malak M</au><au>Almotairi, Ahmad</au><au>Alajlan, Saad</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Intravenous Immunoglobulin in the Management of Lupus Erythematosus Panniculitis</atitle><jtitle>Curēus (Palo Alto, CA)</jtitle><addtitle>Cureus</addtitle><date>2020-01-27</date><risdate>2020</risdate><volume>12</volume><issue>1</issue><spage>e6790</spage><pages>e6790-</pages><issn>2168-8184</issn><eissn>2168-8184</eissn><abstract>Lupus erythematosus panniculitis (LEP) is a rare variant of cutaneous lupus erythematosus (CLE). It is characterized by the presence of a chronic inflammatory process involving the deep dermis and subcutaneous tissues. It commonly presents as deep indurated nodules or sharply demarcated plaques. Antimalarial medications are considered first-line therapy for most cases of LEP while systemic corticosteroids are saved for more resistant lesions. Intravenous immunoglobulin (IVIG) is made up of concentrated polyclonal immunoglobulin G (IgG) fractionated from the blood of healthy blood donors. Nowadays, it is used for the treatment of numerous autoimmune and systemic inflammatory diseases. In this case, we report the case of a female with multiple LEP and discoid lupus erythematosus (DLE) lesions refractory to multiple standard therapy modalities that responded dramatically to IVIG.</abstract><cop>United States</cop><pub>Cureus Inc</pub><pmid>32025447</pmid><doi>10.7759/cureus.6790</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2168-8184
ispartof Curēus (Palo Alto, CA), 2020-01, Vol.12 (1), p.e6790
issn 2168-8184
2168-8184
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6988482
source Open Access: PubMed Central; Publicly Available Content Database
subjects Alopecia
Atrophy
Baldness
Blood & organ donations
Case reports
Dermatitis
Dermatology
Drug dosages
Immunoglobulins
Internal Medicine
Lupus
Pain
Rheumatology
title Intravenous Immunoglobulin in the Management of Lupus Erythematosus Panniculitis
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T19%3A58%3A48IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Intravenous%20Immunoglobulin%20in%20the%20Management%20of%20Lupus%20Erythematosus%20Panniculitis&rft.jtitle=Cur%C4%93us%20(Palo%20Alto,%20CA)&rft.au=AlQadri,%20Nada%20G&rft.date=2020-01-27&rft.volume=12&rft.issue=1&rft.spage=e6790&rft.pages=e6790-&rft.issn=2168-8184&rft.eissn=2168-8184&rft_id=info:doi/10.7759/cureus.6790&rft_dat=%3Cproquest_pubme%3E2368381422%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c264t-a6b6db5b8fa90f56240f3a26d5fe255f435027ecf1151a8b40f48cc6fd6f812d3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2368381422&rft_id=info:pmid/32025447&rfr_iscdi=true